AstraZeneca is a big company that makes medicines to help people with different health problems. Some people who buy and sell parts of this company are doing some strange things with their money that make other people curious. The article talks about how well the company is doing, how much its part is worth, and when it will tell everyone how much money it made last. Read from source...

1. The title of the article is misleading and sensationalized. It implies that there is something unusual or suspicious about AstraZeneca's options activity, which may not be the case. A more accurate title could be "Examining AstraZeneca's Options Trading Volume and Price Performance".
2. The article does not provide any evidence or data to support its claims that there is unusual or significant options activity happening at AstraZeneca. It only mentions some trading volume numbers, but without context, comparisons, or trends, they are meaningless. The author should have conducted a more thorough and quantitative analysis of the options market dynamics and patterns for AstraZeneca and its peers.
3. The article makes several vague and unsubstantiated statements about the company's performance, such as "the majority of sales come from international markets" or "the stock is may be approaching overbought". These statements are either irrelevant or misleading for understanding the options activity at AstraZeneca. The author should have focused on explaining how the options market reflects the underlying fundamentals and expectations of the company, rather than making assumptions or speculations.
4. The article ends with a generic and uninformative advice for traders who are interested in options trading. It does not offer any specific insights or strategies that could help them capitalize on the opportunities or risks associated with AstraZeneca's options. The author should have provided more actionable and practical tips, such as what types of options to trade, how to set prices, when to enter or exit positions, etc.

- Given the recent unusual options activity in AstraZeneca (AZN), one potential strategy is to buy a call option with a strike price of $70 and an expiration date of one month, as this would allow you to benefit from a possible increase in the stock price while limiting your downside risk.
- Another strategy is to sell a put option with a strike price of $65 and an expiration date of one month, as this would generate income for you while also reducing your exposure to potential losses if the stock price drops. This is known as a credit spread or a bull call spread trade.
- A third strategy is to buy a put option with a strike price of $60 and an expiration date of one month, as this would protect you from a decline in the stock price while still leaving room for upside potential if the market reacts positively to the earnings report or other positive news. This is known as a bear call spread trade.
- A fourth strategy is to buy a call option with a strike price of $70 and an expiration date of two months, as this would give you more time for the stock price to move in your favor while also increasing your premium or cost basis. This is known as a long call trade.
- A fifth strategy is to sell a call option with a strike price of $65 and an expiration date of two months, as this would generate income for you while also limiting your exposure to potential losses if the stock price rallies. This is known as a short call trade or a bull put spread trade.
- A sixth strategy is to buy a put option with a strike price of $60 and an expiration date of two months, as this would give you more time for the stock price to decline while also reducing your premium or cost basis. This is known as a long put trade.
- A seventh strategy is to sell a put option with a strike price of $65 and an expiration date of three months, as this would generate income for you while also providing more protection from potential losses if the stock price drifts lower. This is known as a short put trade or a bear call spread trade.
- An eighth strategy is to buy a call option with a strike price of $70 and an expiration date of three months, as this would give you even more time for the stock price to increase while also increasing your premium or cost basis. This is known as a long call trade.